TP53 and hepatocellular carcinoma: In the HSG group, 228 (84.13%) of 271 HCC samples were mutated, and the genes with higher mutations were frequently mutated in tumours, such as TP53, CTNNB1, TTN and MUC16 (Figure 4C).